Medine Cumhur Cure

19PUBLICATIONS
13CO-AUTHORS
Predictive and prognostic markersPainMolecular targetsNutrigenomics and personalised nutritionCardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|May 21, 2025
Emerging risks of lipid-lowering therapy and low LDL levels: implications for eye, brain, and new-onset diabetes.

Erkan Cure, Medine Cumhur Cure

|Nov 07, 2024
Proprotein convertase subtilisin/kexin type 9 and apelin in fibromyalgia syndrome.

Nevsun Pihtili Taş, Rabia Aydogan Baykara, Ayhan Kamanli

|Apr 03, 2024
Why have SGLT2 Inhibitors Failed to Achieve the Desired Success in COVID-19?

Medine Cumhur Cure, Erkan Cure

|Nov 01, 2022
Insulin may increase disease severity and mortality of COVID-19 through Na+/H+ exchanger in patients with type 1 and type 2 diabetes mellitus.

E Cure, M Cumhur Cure

|May 03, 2022
Proprotein convertase subtilisin/kexin type 9 is associated with atherosclerosis in patients with Behcet's disease.

Rabia Aydogan Baykara, Pinar Diydem Yilmaz, Mevlüt Hakan Göktepe

|Jul 21, 2021
Effects of the Na+/H+ Ion Exchanger on Susceptibility to COVID-19 and the Course of the Disease.

Medine Cumhur Cure, Erkan Cure

Pageof 4

Frequent Collaborators

19 joint publications

Erkan Cure

4 joint publications

Adem Kucuk

2 joint publications

Rabia Aydogan Baykara

1 joint publications

Tevfik Bulent Ilcol